Anavex Life Sciences Corp. (AVXL) Stock Overview
Explore Anavex Life Sciences Corp.’s financial performance, market position, analyst ratings, and future outlook.
Anavex Life Sciences Corp. (AVXL)
Key Financials
Key Financials
Market Cap
222.4M
P/E Ratio
-9.09
EPS (TTM)
$-0.16
ROE
-0.21%
AVXL Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Anavex Life Sciences Corp. (NASDAQ: AVXL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Anavex Life Sciences Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of AVXL on the NASDAQ shows an RSI of 33.70, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $2.22 for the NASDAQ listing.
Key metrics behind Anavex Life Sciences Corp.'s NASDAQ-traded stock include a P/E ratio of -9.09 and a market capitalization of 222.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of AVXL on the NASDAQ.